The 20 Best Triple-Negative Breast Cancer Doctors Near Me in Ann Arbor, MI

Dr. Sofia Merajver received a doctoral degree in physics from the University of Maryland and a medical degree from the University of Michigan. She completed a residency in internal medicine and a fellowship in oncology at the University of Michigan before joining the faculty in 1994. Dr. Merajver, an expert in breast cancer genetics, is the medical director of the Breast and Ovarian Cancer Risk Evaluation Program at the U-M Rogel Cancer Center. Her research interests include the molecular genetics of breast cancer, gene function and cancer risk assessment. She enjoys literature, music and outdoor activities with her family. Dr. Merajver is rated as an Elite provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Breast Cancer, Triple-Negative Breast Cancer, and Angiosarcoma. Dr. Merajver is board certified in Medical Oncology.

Max Wicha is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Wicha is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Tissue Biopsy.

Lori Pierce is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Pierce is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Angiosarcoma, and Intraductal Papilloma.

Dr. Jeruss is a Professor of Surgery and the Director of the University of Michigan Breast Care Center. She also holds appointments in the Departments of Pathology and Biomedical Engineering at the University of Michigan. Dr. Jeruss received her undergraduate degree in neuroscience and history from Brandeis University and her medical degree from the University of Vermont. Dr. Jeruss completed her General Surgery residency training at Northwestern University Medical School and holds a PhD from Northwestern, having done her dissertation in the field of breast cancer biology. She completed her fellowship in Breast Surgical Oncology at M.D. Anderson Cancer Center in 2006, and returned to Northwestern as Associate Professor of Surgery in the Division of Breast Surgery before joining the University of Michigan faculty.Dr. Jeruss is board certified in General Surgery and is a member of several professional societies. Through her basic and clinical research program, Dr. Jeruss has been actively involved in the training of high school students, undergraduates, graduate students at the PhD and post-doctoral levels, medical students, and residents. She has published numerous manuscripts and book chapters, and has also received many awards for teaching and research. Dr. Jeruss is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, Mastectomy, and Lymphadenectomy. Dr. Jeruss is board certified in Surgery.

Dr. Morikawa joined the faculty in August 2014. After earning her M.Mus. in Piano Performance and M.PH in Epidemiology and Biostatistics from Boston University, Dr. Morikawa received her MD/Ph.D. at the Emory University School of Medicine. After completing her internal medicine residency training at Emory, she underwent fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center. In 2014, she joined the faculty of the University of Michigan. She specializes in the care of patients with breast cancer at the Rogel Cancer Center. Her research involves clinical and translational investigations in breast cancer as well as brain and leptomeningeal metastases from solid tumors. Dr. Morikawa is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Morikawa is board certified in Internal Medicine and Medical Oncology.

Dr. Schott is a Professor of Medicine and is the Associate Director of Clinical Research for the Rogel Cancer Center. She is an expert in the field of breast cancer, has an active breast cancer practice, and frequently gives lectures and publishes about breast cancer treatment. Her research is focused on the development of new treatments for breast cancer, and the testing of these treatments in clinical trials. Dr. Schott is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, HER2 Negative Breast Cancer, and Tissue Biopsy.

Dr. Jeffrey Smerage is a hematologist/oncologist specializing in breast cancer. He received both a medical and doctoral degree from the University of Florida and then went on to residency training at the University of Virginia. In 2004, after completing a fellowship in hematology and oncology at the University of Michigan, Dr. Smerage joined the faculty of the Department of Internal Medicine and began his practice in the Breast Care Center. Dr. Smerage is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Paget Disease of the Breast. Dr. Smerage is board certified in Medical Oncology and Clinical Informatics.

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Dr. Derek Bergsma is active in clinical practice at the Lacks Cancer Center Department of Radiation Oncology in Grand Rapids. He received his undergraduate degree from Grand Valley State University and then worked in cancer immunodiagnostics at Van Andel Institute before obtaining his medical degree from Michigan State University College of Human Medicine. He completed both internship and Radiation Oncology residency at the University of Rochester in Rochester, NY. Dr. Bergsma is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Brain Tumor, Astrocytoma, and Oligodendroglioma. Dr. Bergsma is board certified in Radiation Oncology.

Terri Bott-Kothari, MD has been in practice for over 16 years treating all disease sites. She completed her medical training at Wayne State University School of Medicine and residency at the University of Cincinnati. Dr. Bott is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Familial Prostate Cancer. Dr. Bott is board certified in Radiation Oncology.

Dr. Erin Cobain is a medical oncologist specializing in the care of patients with breast cancer and inherited cancer predisposition. She serves at Co-Director of the Breast Cancer Clinical Research Team at the Rogel Cancer Center. Dr. Cobain has been on faculty at the University of Michigan since 2016, when she completed her fellowship training. Dr. Cobain specializes in the care of patients with all types of breast cancer and those individuals who are at high risk of developing breast cancer. Dr. Cobain’s research interests include understanding how genetic and genomic testing can be utilized to personalize breast cancer therapy and use of immunotherapy treatments in breast cancer. Dr. Cobain serves as the Principal Investigator of a National Cancer Institute sponsored clinical trial exploring the role of combination chemotherapy and immunotherapy treatment in patients with hormone receptor positive, HER2 negative early-stage breast cancer with high genomic risk. Dr. Cobain is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.

Nithya Ramnath is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Ramnath is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Pleuropulmonary Blastoma.

Dr. Burness is driven by a desire to improve therapies for breast cancer patients. Her research arises from her clinical experiences in treating breast cancer patients. Her research focus is on the development of therapies to target cancer stem cells, specifically ways to alter DNA repair mechanisms and inflammation in cancer stem cells. This innovative approach to treating breast cancer holds promise for identifying new therapeutic targets and improving therapeutic regimens. Dr. Burness studies these approaches in the laboratory and in clinical trials, with the goal of rapidly translating her laboratory findings into use in the clinic to improve outcomes for breast cancer patients. Dr. Burness is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Breast Cancer in Men, Angiosarcoma, and Paget Disease of the Breast. Dr. Burness is board certified in Internal Medicine and Medical Oncology.

Dr. Tasha Hughes is a Clinical Associate Professor of Surgery and a surgical oncologist at the University of Michigan. Her clinical efforts are focused on the treatment of breast cancer and melanoma. She is a health services research with a program centered around provider communication, provider bias and health care safety and quality.Dr. Hughes completed her surgical oncology training at Ohio State University Wexner Medical Center and James Comprehensive Cancer Society and her residency at Rush University Medical Center and John H. Stroger Hospital of Cook County in Chicago, IL. Dr. Hughes is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Lymphadenectomy.

Dr. Norah Lynn Henry is a medical oncologist, Associate Director of Community Outreach and Engagement at the Rogel Cancer Center, and Co-Chair of the Symptom Management and Survivorship Committee for the SWOG Cancer Research Network.Dr. Henry specializes in the care of patients with all stages and all types of breast cancer. Her research focuses on personalizing treatment for breast cancer. She studies treatments for breast cancer as well as ways to manage symptoms and side effects that arise from the cancer or its treatment. Her goal is to provide effective treatments for breast cancer while maintaining the quality of life of each patient. In addition, she works with scientists at the University of Michigan to translate their lab findings into clinical trials. Dr. Henry is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Salpingo-Oophorectomy. Dr. Henry is board certified in Medical Oncology.

Steven Allen is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Lung Cancer, HER-2 Positive Breast Cancer, and Pleuropulmonary Blastoma. Dr. Allen is board certified in Radiation Oncology.

Dr. James Hayman received his medical and master of business administration degrees simultaneously from the University of Chicago in 1991. Following an internship in Evanston, Ill., he began his radiation oncology residency at the Joint Center for Radiation Therapy at Harvard Medical School. He joined the University of Michigan faculty immediately following his residency in 1996 and currently serves as the director of the Clinical Division of the Department of Radiation Oncology. Dr. Hayman's clinical interests include the management of lung, esophageal, breast and central nervous system malignancies. He is also active in the area of health services research. Dr. Hayman is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Melanoma of the Eye, Merkel Cell Carcinoma, and Small Cell Lung Cancer (SCLC). Dr. Hayman is board certified in Radiation Oncology and Hospice & Palliative Med.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Borislav Hristov is a Radiation Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Hristov is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His clinical expertise encompasses Metastatic Brain Tumor, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Diffuse Midline Glioma H3 K27M-Mutant. Dr. Hristov is board certified in Radiation Oncology.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Triple-Negative Breast Cancer. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.